Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01HRU
|
|||
| Former ID |
DIB009449
|
|||
| Drug Name |
SBR-759
|
|||
| Synonyms |
SBR-759A; Hyperphosphatemia therapy, Sebo/Novartis; Phosphate binding agent (kidney disease), Sebo/Novartis; Phosphate binding agent (renal disease), Sebo/Novartis
Click to Show/Hide
|
|||
| Indication | Hypophosphatasia [ICD-11: 5C64.3; ICD-10: E83.3; ICD-9: 275.3] | Phase 3 | [1] | |
| Company |
Sebo GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01069692) Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.